GENE ONLINE|News &
Opinion
Blog

Pfizer
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Pfizer Acquires Seagen for $43 Billion to Capture Leading Position in Oncology
2023-03-14
Pfizer’s Fast-Acting Migraine Nasal Spray Takes Home US Approval
2023-03-13
Pfizer and GSK Neck and Neck for First FDA-Approved RSV Vaccine
2023-03-03
Pfizer’s RSV Vaccine Wins Support From FDA Advisory Panel for Use in Older Adults
2023-03-01
Pfizer Trumpets Lancet Publication Of Migraine Drug’s Phase 3 Results
2023-02-18
Pfizer’s Hemophilia B Gene Therapy Meets Phase 3 Endpoints
2022-12-30
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
Pfizer Begins Phase 2 Of Diabetes Drug, Triggering $10 Million Milestone To Sosei Heptares
2022-12-22
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
Pfizer to Raise COVID-19 Vaccine Prices Amidst Rising Flu Cases
2022-10-24
Pfizer Opts In On Neurological Target In Voyager Deal, Leaving $290 Million In Milestones
2022-10-05
Pfizer, Sangamo Re-Opens Enrolment For Hemophilia A Gene Therapy
2022-09-26
Pfizer Pledges 6 million COVID-19 Treatment Courses to Global Fund
2022-09-22
Pfizer’s Pentavalent Vaccine Shines in Phase 3 Trials Before BLA Submission
2022-09-16
1 2 3 8
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
AffaMed Technologies Announces TFDA Approval of MINI WELL, MINI WELL PROXA, MINI WELL TORIC and MINI 4 Ready IOLs for Cataract Treatment in Taiwan
2023-03-19
Scroll to Top